| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |